TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04163094

Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“Despite the extension of the original recruitment period, the target number of evaluable patients defined in the study protocol could not be reached and recruitment for the trial was stopped at that point of time.”

The sponsor’s own words in the registry.

Life of this trial

201920202021202220232024Registered2019-11-06Started2019-11-25Stopped2023-06-26

Vital statistics

Status
Terminated
Phase
Phase 1
Sponsor
University Medical Center Groningen
Sponsor type
University, hospital or other
Conditions
Ovarian Cancer
Interventions
W_ova1 Vaccine
Participants
8
Sites
1
Countries
Netherlands

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.